These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 19958654
1. [Therapeutic effects of compound glycyrrhizin liposome on fibrosis of the rats with nonalcoholic steatohepatitis]. Ye HJ, Wei SL, Wang HC, Liu XY, Wan HJ, Yi XR, Yuan YC, Kong XP. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):877-8. PubMed ID: 19958654 [No Abstract] [Full Text] [Related]
2. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. Ma T, Huang C, Zong G, Zha D, Meng X, Li J, Tang W. J Pharm Pharmacol; 2011 Apr; 63(4):587-93. PubMed ID: 21401612 [Abstract] [Full Text] [Related]
3. Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis. Lin HJ, Chen JY, Lin CF, Kao ST, Cheng JC, Chen HL, Chen CM. J Ethnopharmacol; 2011 Apr 12; 134(3):953-60. PubMed ID: 21333722 [Abstract] [Full Text] [Related]
4. [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study]. Mao YM, Zeng MD, Chen Y, Chen CW, Fu QC, Cai X, Wu SM, Chen YG, Sun Y, Li J, Sui YH, Zhao W, Lu LG, Cao AP, Chen HZ. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 12; 17(11):847-51. PubMed ID: 19958646 [Abstract] [Full Text] [Related]
5. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Hong XZ, Li LD, Wu LM. Clin Exp Pharmacol Physiol; 2007 Nov 12; 34(1-2):27-35. PubMed ID: 17201732 [Abstract] [Full Text] [Related]
6. [Inhibitory effect of anluohuaxianwan on experimental hepatic fibrosis in rats]. Tan XH, Li CQ, Zou SR, Xie M, Zhang AM, Li WL, Li XY, Huang HF, Lei CL. Zhonghua Gan Zang Bing Za Zhi; 2010 Jan 12; 18(1):9-12. PubMed ID: 20128961 [Abstract] [Full Text] [Related]
7. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K. J Gastroenterol Hepatol; 2007 Nov 12; 22(11):2009-14. PubMed ID: 17914984 [Abstract] [Full Text] [Related]
8. [Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule]. Sun M, Shan JZ, Zhang GP, Ying HZ. Zhongguo Zhong Yao Za Zhi; 2007 Apr 12; 32(7):616-9. PubMed ID: 17583205 [Abstract] [Full Text] [Related]
9. In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats. Kimura M, Moro T, Motegi H, Maruyama H, Sekine M, Okamoto H, Inoue H, Sato T, Ogihara M. Eur J Pharmacol; 2008 Jan 28; 579(1-3):357-64. PubMed ID: 18022618 [Abstract] [Full Text] [Related]
10. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. Satapathy SK, Sakhuja P, Malhotra V, Sharma BC, Sarin SK. J Gastroenterol Hepatol; 2007 May 28; 22(5):634-8. PubMed ID: 17444848 [Abstract] [Full Text] [Related]
11. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY, Pan JQ, Lv JH. Zhongguo Zhong Yao Za Zhi; 2008 Oct 28; 33(20):2385-90. PubMed ID: 19157135 [Abstract] [Full Text] [Related]
12. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. Zou YH, Yang Y, Li J, Wu Q, Li WP, Lu JT, Roberts MS. J Ethnopharmacol; 2008 Dec 08; 120(3):452-7. PubMed ID: 18951966 [Abstract] [Full Text] [Related]
13. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Obes Surg; 2005 Mar 08; 15(3):310-5. PubMed ID: 15826462 [Abstract] [Full Text] [Related]
14. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis]. Zhang H, Feng Q, Li HS, Chen SD, Wang XN, Peng JH, Zhang N, Hu YY. Zhong Xi Yi Jie He Xue Bao; 2008 Sep 08; 6(9):928-33. PubMed ID: 18782536 [Abstract] [Full Text] [Related]
15. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, van Heek M, Hwa JJ. Eur J Pharmacol; 2008 Apr 14; 584(1):118-24. PubMed ID: 18329014 [Abstract] [Full Text] [Related]
16. [Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats]. Zhang ZP, You TT, Zou LY, Wu T, Wu Y, Cui L. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul 14; 28(7):1109-13. PubMed ID: 18676239 [Abstract] [Full Text] [Related]
17. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease]. Tan Y, Zhang JN, Chen JH, Wang LJ, Liu HX. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 14; 17(11):821-5. PubMed ID: 19958640 [Abstract] [Full Text] [Related]
18. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. Wang JQ, Li J, Zou YH, Cheng WM, Lu C, Zhang L, Ge JF, Huang C, Jin Y, Lv XW, Hu CM, Liu LP. J Ethnopharmacol; 2009 Jan 12; 121(1):54-60. PubMed ID: 18977425 [Abstract] [Full Text] [Related]
19. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats. Murayama H, Ikemoto M, Nagata A. J Gastroenterol Hepatol; 2009 Feb 12; 24(2):270-7. PubMed ID: 18823438 [Abstract] [Full Text] [Related]
20. Therapeutic Effect of Glycyrrhizin Arginine Salt on Rat Cholestatic Cirrhosis and its Mechanism. Zhang H, Lin Y, Zhen Y, Hu G, Meng X, Li X, Men X. Am J Chin Med; 2018 Feb 12; 46(5):1111-1127. PubMed ID: 29976082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]